• Home
  • Ask Questions
  • Risk + Prevention
  • Diagnosis
  • Management
  • Tips + Tools
  • Site Map

THE "NEW" PROSTATE CANCER INFOLINK

Entries RSS | Comments RSS
  • Follow The "New" Prostate Cancer InfoLink news blog on TWITTER or FACEBOOK.
  • The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
  • A service of

    Prostate Cancer International.

    pcai_cmyk

  • Awards


    Prostate Cancer International Nonprofit Overview and Reviews on GreatNonprofits

  • Other PCI web sites

    El Cáncer de Próstata Latinoamérica

    Prostate Cancer Africa

    Prostate Cancer Caribbean

    Solidarité Prostate InfoLink

  • Copyright © 2008-18 Prostate Cancer International, Inc.

I-131-MIP-1095 to enter randomized, Phase II clinical trial

Posted on October 13, 2018 by Sitemaster

As we reported last year, a new radiopharmaceutical has entered the pack. … READ MORE …

Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: castration-resistant, injectable, Iodine-131-MIP-1095, metastatic, radiation, systenic, therapy | 3 Comments »

  • Donate

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

    • Active surveillance: a future perspective
    • NCCN guidance on initial management of low-risk, localized prostate cancer (redux)
    • Projected attendance at AS research conference
    • Registration for major active surveillance (AS) research conference now open
    • NCCN guidance on the initial management of low-risk, localized prostate cancer
    • Exceptions to “early salvage” radiation treatment for recurrence after prostatectomy
    • Chances to hear from the new President and CEO of the Prostate Cancer Foundation
    • More than 25 organizations join new Prostate Cancer Impact Alliance
    • Educational opportunities on September 29 upcoming
    • Whole-pelvic radiation therapy for high-risk patients
    • Fear of prostate cancer recurrence post-surgery
    • Timing of initiation of ADT for men with biochemical progression after first-line surgery
    • Rethinking risk stratification for radiation therapy
    • AS research survey: your help still needed
    • Helpful upcoming webinars this week
  • … and Archives

Blog at WordPress.com. WP Designer.

  • Follow Following
    • THE "NEW" PROSTATE CANCER INFOLINK
    • Join 1,369 other followers
    • Already have a WordPress.com account? Log in now.
    • THE "NEW" PROSTATE CANCER INFOLINK
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar